Cargando…

SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection()

Detalles Bibliográficos
Autor principal:	Tsiftsoglou, Stefanos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997388/ https://www.ncbi.nlm.nih.gov/pubmed/33838929 http://dx.doi.org/10.1016/j.molimm.2021.03.021

Ejemplares similares

Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies
por: Tsiftsoglou, Stefanos A.
Publicado: (2023)

Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity
por: Nascimento, Eduardo J. M., et al.
Publicado: (2009)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

AMD and the alternative complement pathway: genetics and functional implications
por: Tan, Perciliz L., et al.
Publicado: (2016)

Genetic variability shapes the alternative pathway complement activity and predisposition to complement‐related diseases
por: Rodríguez de Córdoba, Santiago
Publicado: (2022)

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
por: Boussier, Jeremy, et al.
Publicado: (2022)

SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb
por: Rajagopal, Vaishnavi, et al.
Publicado: (2023)

The alternative complement pathway revisited
por: Harboe, Morten, et al.
Publicado: (2008)

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
por: Marcos‐Jiménez, Ana, et al.
Publicado: (2021)

Complement alternative pathway genetic variation and Dengue infection in the Thai population
por: Kraivong, R, et al.
Publicado: (2013)

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway
por: Jiang, Haixiang, et al.
Publicado: (2001)

Interferon-β1a-Induced Thrombotic Microangiopathy: Possible Implication of the Alternative Pathway of the Complement
por: Taghavi, Maxime, et al.
Publicado: (2022)

Genetic variant in complement receptor 1 (CR1, CD35) is associated with a cluster of severe fatal COVID-19 in a family
por: Danial-Farran, N., et al.
Publicado: (2023)

Is There any Alternative Receptor for SARS-CoV-2?
por: Shahriari Felordi, Mahtab, et al.
Publicado: (2021)

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
por: Yu, Jia, et al.
Publicado: (2020)

Genetic variants associated with SARS-CoV-2 infection also affect lung function and asthma severity
por: Silva, Milca de Jesus, et al.
Publicado: (2023)

Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19
por: Niederreiter, Janina, et al.
Publicado: (2022)

“Nose Job": Possible Side Effects of Sars-Cov-2
por: King, Robert
Publicado: (2022)

Possibilities for the Entrance of SARS-Cov-2 as an Archaeal Virus into the Ecosystem
por: Mirshafiey, Abbas, et al.
Publicado: (2021)

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
por: Prokopez, Cintia R., et al.
Publicado: (2021)

THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1974)

Quantitative Modeling of the Alternative Pathway of the Complement System
por: Zewde, Nehemiah, et al.
Publicado: (2016)

Mathematical Modelling of Alternative Pathway of Complement System
por: Bakshi, Suruchi, et al.
Publicado: (2020)

Structures of the rat complement regulator CrrY
por: Roversi, Pietro, et al.
Publicado: (2011)

Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19
por: Niederreiter, Janina, et al.
Publicado: (2023)

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
por: Barratt, Jonathan, et al.
Publicado: (2021)

Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant
por: Louis, Guillaume, et al.
Publicado: (2021)

Pathogenicity of Sars-Cov-2 Spike Protein Variants Correlates with Coagulation and Complement Assays
por: Gerber, Gloria, et al.
Publicado: (2022)

Athletic performance is not affected by SARS-CoV-2
por: Siopis, G.
Publicado: (2022)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Setting the criteria for SARS-CoV-2 reinfection – six possible cases
por: Tomassini, Sara, et al.
Publicado: (2021)

Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids
por: Gowrishankar, S., et al.
Publicado: (2020)

Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Mechanism of action of factor D of the alternative complement pathway
Publicado: (1978)

Blockade of Alternative Complement Pathway in Dense Deposit Disease
por: Berthe-Aucejo, Aurore, et al.
Publicado: (2014)

Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
por: Segers, Filip M., et al.
Publicado: (2014)

Preanalytical classical and alternative complement pathway activity loss
por: Vercauteren, Koen O.A., et al.
Publicado: (2019)

Low‐molecular weight inhibitors of the alternative complement pathway
por: Schubart, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gccutnharl1ajtofqg5l7hpk1n